Meridian Bioscience to acquire GenePOC's molecular diagnostics business

Debiopharm announced that its subsidiary GenePOC has reached an agreement for Meridian Bioscience to acquire GenePOC's molecular diagnostics business portfolio, including the revogene device and rapid molecular assays.

“Meridian Bioscience has a long, proven history in both the laboratory diagnostics and life sciences markets.”debiopharm.com

• 1 source
• debiopharm.comGenePOC, a subsidiary of Debiopharm, reaches an agreement with Meridian Bioscience for the acquisition of their molecular diagnostics businessApr 30, 2019

Summarized from public sources; check the original articles before acting on it.